Literature DB >> 26926173

Inhibition of pulmonary metastasis by Emilia sonchifolia (L.) DC: An in vivo experimental study.

Gilcy K George1, Girija Kuttan2.   

Abstract

BACKGROUND: Emilia sonchifolia (L.) DC is a widely distributed medicinal herb used mainly in the indigenous Ayurvedic system of medicine in India. This plant is one among the ten sacred plants of Kerala state in India, collectively known as Dasapushpam.
PURPOSE: To assess the therapeutic efficacy of this well-known medicinal plant in a catastrophic complication like metastatic cancer progression. This study further aimed to scientifically validate the traditional medicinal use of this sacred plant. STUDY
DESIGN: Highly metastatic B16F10 melanoma will spontaneously metastasize in C57BL/6 mice and is accepted as a useful murine model for the study on metastasis. Three different experimental modalities of prophylactic, simultaneous and after tumour development were used for data accumulation and analysis.
METHODS: Whole plant genuine extract of E. sonchifolia (25 mg/kg bodyweight) was administered intraperitoneally to C57BL/6 mice. Animals were sacrificed on 21st day after tumour induction and the lung tumour nodules were counted. Various lung and serum biochemical parameters along with major cytokine levels were recorded. Survival rate was monitored. Histopathology of the lung tissue and expression studies of the major genes involved in metastasis was also carried out.
RESULTS: E. sonchifolia significantly inhibited pulmonary tumour formation and increased the life span of animals. Lung collagen hydroxyproline, uronic acid, hexosamine, serum sialic acid, γ-glutamyl transpeptidase, vascular endothelial growth factor (VEGF), granulocyte monocyte colony-stimulating factor and other cytokine levels were significantly lowered in the treated group of animals. Histopathological analysis was also correlated with these findings. E. sonchifolia down regulated the expression of matrix metalloproteinases; extracellular signal-regulated kinases and VEGF at the same time up regulated the expression of tissue inhibitor of matrix metalloproteinases.
CONCLUSION: Previous studies on E. sonchifolia proved its significant biological properties including anti-tumour, anti-inflammatory and antioxidant activities. Present report is so far the first study to demonstrate the anti-metastatic potential of this medicinal herb justifying its conventional use in the traditional medicine.
Copyright © 2015 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  B16F10 melanoma; Cytokines; Emilia sonchifolia; Matrix metalloproteinase; Tissue inhibitor of matrix metalloproteinase; Vascular endothelial growth factor

Mesh:

Substances:

Year:  2015        PMID: 26926173     DOI: 10.1016/j.phymed.2015.11.017

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  4 in total

1.  Evaluation of the anti-inflammatory and urotoxicity ameliorative effects of γ-humulene containing active fraction of Emilia sonchifolia (L.) DC.

Authors:  Gilcy George Kallivalappil; Girija Kuttan
Journal:  Inflammopharmacology       Date:  2017-12-09       Impact factor: 4.473

2.  Screening of plants from the Brazilian Atlantic Forest led to the identification of Athenaea velutina (Solanaceae) as a novel source of antimetastatic agents.

Authors:  Alisson A Almeida; Graziela D A Lima; Marcos V R C Simão; Gabriela A Moreira; Raoni P Siqueira; Ana C Zanatta; Wagner Vilegas; Mariana Machado-Neves; Gustavo C Bressan; João P V Leite
Journal:  Int J Exp Pathol       Date:  2020-05-26       Impact factor: 1.925

3.  Altered presence of extra cellular matrix components in murine skin cancer: Modulation by Azadirachta indica leaf extract.

Authors:  N A Chugh; A Koul
Journal:  J Tradit Complement Med       Date:  2020-03-29

4.  Evaluation of Antiangiogenic Efficacy of Emilia sonchifolia (L.) DC on Tumor-Specific Neovessel Formation by Regulating MMPs, VEGF, and Proinflammatory Cytokines.

Authors:  George K Gilcy; Girija Kuttan
Journal:  Integr Cancer Ther       Date:  2016-05-04       Impact factor: 3.279

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.